Template:SUIT-037: Difference between revisions
From Bioblast
No edit summary |
No edit summary Tag: Reverted |
||
Line 1: | Line 1: | ||
[[Image:SUIT-MitoFit.png|right|190px|link=http://www.bioblast.at/index.php/MitoPedia:_SUIT |MitoPedia: SUIT]] | [[Image:SUIT-MitoFit.png|right|190px|link=http://www.bioblast.at/index.php/MitoPedia:_SUIT |MitoPedia: SUIT]] | ||
== Steps and respiratory states == | == Steps and respiratory states == | ||
[[File:1D;2M.1; | [[File:1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U;9Rot;10Ama.png|400px]] | ||
{| class="wikitable" border="1" | {| class="wikitable" border="1" | ||
Line 22: | Line 22: | ||
| 1D;2M.1 | | 1D;2M.1 | ||
*{{Template:SUIT M_low}} | *{{Template:SUIT M_low}} | ||
*Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | |||
|- | |- | ||
| | | 2H2O | ||
| | | ย | ||
| | | ย | ||
| | | ย | ||
| 1D;2M.1; | | 1D;2M.1;2H2O | ||
*{{Template:SUIT F}} ย | *{{Template:SUIT F}} ย | ||
Line 34: | Line 35: | ||
|- | |- | ||
| 3c | | 3c | ||
| | | ย | ||
| | | ย | ||
| | | ย | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c | ||
*{{Template:SUIT OXPHOS}} ย | *{{Template:SUIT OXPHOS}} ย | ||
*{{Template:SUIT c}} | *{{Template:SUIT c}} | ||
|- | |- | ||
| | | 3M.2 | ||
| | | ย | ||
| | | ย | ||
| | | ย | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2 | ||
*Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | *Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | ||
*{{Template:SUIT M_high}} ย | *{{Template:SUIT M_high}} ย | ||
Line 56: | Line 55: | ||
|- | |- | ||
| | | 3M.5 | ||
| | | ย | ||
| | | ย | ||
| | | ย | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5 | ||
*Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | *Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | ||
*{{Template:SUIT M_high}} ย | *{{Template:SUIT M_high}} ย | ||
Line 68: | Line 66: | ||
|- | |- | ||
| | | 3M1 | ||
| | | ย | ||
| | | ย | ||
| | | ย | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1 | ||
*Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | *Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | ||
*{{Template:SUIT M_high}} ย | *{{Template:SUIT M_high}} ย | ||
Line 80: | Line 77: | ||
|- | |- | ||
| | | 3M2 | ||
| | | ย | ||
| | | ย | ||
| | | ย | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2 | ||
*Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | *Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | ||
*{{Template:SUIT M_high}} ย | *{{Template:SUIT M_high}} ย | ||
Line 92: | Line 88: | ||
|- | |- | ||
| | | 4P | ||
| [[ | | [[PM]]<sub>''P''</sub> | ||
| [[ | | [[N]] | ||
| | | CI | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P | ||
*{{Template:SUIT | *{{Template:SUIT N}} ย | ||
*{{Template:SUIT OXPHOS}} | *{{Template:SUIT OXPHOS}} | ||
|- | |- | ||
| | | 5G | ||
| [[ | | [[PGM]]<sub>''P''</sub> | ||
| [[ | | [[N]] | ||
| | | CI | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G | ||
*{{Template:SUIT | *{{Template:SUIT N}} ย | ||
*{{Template:SUIT OXPHOS}} | *{{Template:SUIT OXPHOS}} | ||
|- | |- | ||
| | | 6S10 | ||
| [[ | | [[PGMS]]<sub>''P''</sub> | ||
| [[ | | [[NS]] | ||
| | | CI<small>&</small>II | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10 | ||
*{{Template:SUIT | *{{Template:SUIT NS}} ย | ||
*{{Template:SUIT OXPHOS}} | *{{Template:SUIT OXPHOS}} | ||
|- | |- | ||
| | | 6S50 | ||
| [[ | | [[PGMS]]<sub>''P''</sub> | ||
| [[ | | [[NS]] | ||
| | | CI<small>&</small>II | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50 | ||
*{{Template:SUIT | *{{Template:SUIT NS}} ย | ||
*{{Template:SUIT OXPHOS}} | *{{Template:SUIT OXPHOS}} | ||
|- | |- | ||
| | | 7Gp | ||
| [[ | | [[PGMSGp]]<sub>''P''</sub> | ||
| [[ | | [[NSGp]] | ||
| | | CI<small>&</small>II<small>&</small>GpDH | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp | ||
*{{Template:SUIT | *{{Template:SUIT NSGp}} ย | ||
*{{Template:SUIT OXPHOS}} | *{{Template:SUIT OXPHOS}} | ||
|- | |- | ||
| | | 8U | ||
| [[ | | [[PGMSGp]]<sub>''E''</sub> | ||
| [[ | | [[NSGp]] | ||
| | | CI<small>&</small>II<small>&</small>GpDH | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U | ||
*{{Template:SUIT | *{{Template:SUIT NSGp}} ย | ||
*{{Template:SUIT U*}} | *{{Template:SUIT U*}} | ||
|- | |- | ||
| | | 9Rot | ||
| [[SGp]]<sub>''E''</sub> | | [[SGp]]<sub>''E''</sub> | ||
| [[SGp]] | | [[SGp]] | ||
| CII<small>&</small>GpDH | | CII<small>&</small>GpDH | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U;9Rot | ||
*{{Template:SUIT SGp}} ย | *{{Template:SUIT SGp}} ย | ||
Line 162: | Line 158: | ||
|- | |- | ||
| | | 10Ama | ||
| [[ROX]] | | [[ROX]] | ||
| ย | | ย | ||
| ย | | ย | ||
| 1D;2M.1; | | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U;9Rot;10Ama | ||
*{{Template:SUIT Ama}} | *{{Template:SUIT Ama}} | ||
Revision as of 10:55, 12 April 2023
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
1D | ROX | 1D
| ||
2M.1 | 1D;2M.1 | |||
2H2O | 1D;2M.1;2H2O
| |||
3c | 1D;2M.1;2H2O;2c
| |||
3M.2 | 1D;2M.1;2H2O;2c;3M.2
| |||
3M.5 | 1D;2M.1;2H2O;2c;3M.2;3M.5
| |||
3M1 | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1
| |||
3M2 | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2
| |||
4P | PMP | N | CI | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P
|
5G | PGMP | N | CI | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G
|
6S10 | PGMSP | NS | CI&II | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10
|
6S50 | PGMSP | NS | CI&II | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50
|
7Gp | PGMSGpP | NSGp | CI&II&GpDH | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp
|
8U | PGMSGpE | NSGp | CI&II&GpDH | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U
|
9Rot | SGpE | SGp | CII&GpDH | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U;9Rot
|
10Ama | ROX | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U;9Rot;10Ama
|
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- ยป Electron transfer pathway
- ยป Fatty acid oxidation pathway control state, F
- ยป NADH electron transfer-pathway state, N
- ยป Succinate pathway control state, S
- ยป NS-pathway control state, NS
- ยป Glycerophosphate pathway control state, Gp
- ยป Complex IV single step, CIV
- ยป Anaplerotic pathway control state
- Pathway control
- Main fuel substrates
- ยป Glutamate, G
- ยป Glycerophosphate, Gp
- ยป Malate, M
- ยป Octanoylcarnitine, Oct
- ยป Pyruvate, P
- ยป Succinate, S
- Main fuel substrates
- Glossary